PubMed

Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial.

Plotkin SA, Starr SE, Friedman HM, Brayman K, Harris S, Jackson S, Tustin NB, Grossman R, Dafoe D, Barker C.

Ann Intern Med. 1991 Apr 1;114(7):525-31.PMID: 1848053 [PubMed - indexed for MEDLINE]Related articles

Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial.

Brayman KL, Dafoe DC, Smythe WR, Barker CF, Perloff LJ, Naji A, Fox IJ, Grossman RA, Jorkasky DK, Starr SE, et al.

Arch Surg. 1988 Dec;123(12):1502-8.PMID: 2847687 [PubMed - indexed for MEDLINE]Related articles

Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients.

Plotkin SA, Higgins R, Kurtz JB, Morris PJ, Campbell DA Jr, Shope TC, Spector SA, Dankner WM.

Transplantation. 1994 Dec 15;58(11):1176-8.PMID: 7992358 [PubMed - indexed for MEDLINE]Related articles

Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants.

Plotkin SA, Smiley ML, Friedman HM, Starr SE, Fleisher GR, Wlodaver C, Dafoe DC, Friedman AD, Grossman RA, Barker CF.

Lancet. 1984 Mar 10;1(8376):528-30.PMID: 6142252 [PubMed - indexed for MEDLINE]Related articles

Cytomegalovirus vaccine: persistence of humoral immunity following immunization of renal transplant candidates.

Sachs GW, Simmons RL, Balfour HH Jr.

Vaccine. 1984 Sep;2(3):215-8.PMID: 6099649 [PubMed - indexed for MEDLINE]Related articles

A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.

Balfour HH Jr, Chace BA, Stapleton JT, Simmons RL, Fryd DS.

N Engl J Med. 1989 May 25;320(21):1381-7.PMID: 2541335 [PubMed - indexed for MEDLINE]Related articles

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial.

Snydman DR, Werner BG, Dougherty NN, Griffith J, Rubin RH, Dienstag JL, Rohrer RH, Freeman R, Jenkins R, Lewis WD, Hammer S, O'Rourke E, Grady GF, Fawaz K, Kaplan MM, Hoffman MA, Katz AT, Doran M; Boston Center for Liver Transplantation CMVIG Study Group.

Ann Intern Med. 1993 Nov 15;119(10):984-91.PMID: 8214995 [PubMed - indexed for MEDLINE]Related articlesFree article

Vaccines for the prevention of human cytomegalovirus infection.

Plotkin SA, Starr SE, Friedman HM, Gonczol E, Brayman K.

Rev Infect Dis. 1990 Sep-Oct;12 Suppl 7:S827-38. Review.PMID: 2173112 [PubMed - indexed for MEDLINE]Related articles

A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.

Heineman TC, Schleiss M, Bernstein DI, Spaete RR, Yan L, Duke G, Prichard M, Wang Z, Yan Q, Sharp MA, Klein N, Arvin AM, Kemble G.

J Infect Dis. 2006 May 15;193(10):1350-60. Epub 2006 Apr 12.PMID: 16619181 [PubMed - indexed for MEDLINE]Related articles

Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.

Boeckh M, Bowden RA, Storer B, Chao NJ, Spielberger R, Tierney DK, Gallez-Hawkins G, Cunningham T, Blume KG, Levitt D, Zaia JA.

Biol Blood Marrow Transplant. 2001;7(6):343-51.PMID: 11464977 [PubMed - indexed for MEDLINE]Related articles

Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial.

Balfour HH Jr, Sachs GW, Welo P, Gehrz RC, Simmons RL, Najarian JS.

Birth Defects Orig Artic Ser. 1984;20(1):289-304. No abstract available. PMID: 6329368 [PubMed - indexed for MEDLINE]Related articles

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

Lowance D, Neumayer HH, Legendre CM, Squifflet JP, Kovarik J, Brennan PJ, Norman D, Mendez R, Keating MR, Coggon GL, Crisp A, Lee IC.

N Engl J Med. 1999 May 13;340(19):1462-70.PMID: 10320384 [PubMed - indexed for MEDLINE]Related articlesFree article

Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial.

Glazer JP, Friedman HM, Grossman RA, Starr SE, Barker CF, Perloff LJ, Huang ES, Plotkin SA.

Ann Intern Med. 1979 Nov;91(5):676-83.PMID: 227299 [PubMed - indexed for MEDLINE]Related articles

The status of cytomegalovirus vaccine.

Starr SE, Friedman HM, Plotkin SA.

Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S964-5. Review.PMID: 1664136 [PubMed - indexed for MEDLINE]Related articles

Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial.

Hibberd PL, Tolkoff-Rubin NE, Conti D, Stuart F, Thistlethwaite JR, Neylan JF, Snydman DR, Freeman R, Lorber MI, Rubin RH.

Ann Intern Med. 1995 Jul 1;123(1):18-26.PMID: 7762909 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group.

Falagas ME, Snydman DR, Griffith J, Ruthazer R, Werner BG.

Ann Intern Med. 1997 Feb 15;126(4):275-9.PMID: 9036799 [PubMed - indexed for MEDLINE]Related articlesFree article

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial.

Winston DJ, Ho WG, Bartoni K, Du Mond C, Ebeling DF, Buhles WC, Champlin RE.

Ann Intern Med. 1993 Feb 1;118(3):179-84.PMID: 8380243 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.

Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL Jr, Levey AS, et al.

N Engl J Med. 1987 Oct 22;317(17):1049-54.PMID: 2821397 [PubMed - indexed for MEDLINE]Related articles

The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation.

Smiley ML, Wlodaver CG, Grossman RA, Barker CF, Perloff LJ, Tustin NB, Starr SE, Plotkin SA, Friedman HM.

Transplantation. 1985 Aug;40(2):157-61.PMID: 2992130 [PubMed - indexed for MEDLINE]Related articles

Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.

Adler SP, Starr SE, Plotkin SA, Hempfling SH, Buis J, Manning ML, Best AM.

J Infect Dis. 1995 Jan;171(1):26-32. Erratum in: J Infect Dis 1995 Apr;171(4):1080. PMID: 7798679 [PubMed - indexed for MEDLINE]Related articles